🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

“Our results demonstrated the limited treatment efficacy of statins in patients on dialysis in the presence of hyperphosphatemia.” New in @CJASN asn.kdny.info/tAlo50IkNbY

Crowdsourcing a #urinesediment. Young woman with micro-hematuria and low level proteinuria for 8-9 months. Relatively fresh sample in clinic. Crenated RBCs for sure. Can I also coin a new term “popcorn RBCs”?? Atypical acanthocytes? Jay R. Seltzer Juan Carlos Q Velez @Nephro_S_Wright

1/ It’s #ThrowbackThursday time again at KI Reports! Let’s start with a quick quiz. What year do you think that continuous renal replacement therapy (CRRT) was used for an adult patient?

Great summary of single-cell analyses for mapping human kidney and investigating pathophysiology of kidney diseases Felix Schreibing Rafael Kramann, MD PhD

Hyperkalemia-Related Discontinuation of RAAS Inhibitors and Clinical Outcomes in #CKD: A Population-Based Cohort Study buff.ly/3ohysrN (FREE temporarily) Silvia Leon Paul Komenda Clara Bohm David Collister Manish M Sood MD Navdeep Tangri SevenOaksCDIC ICES #VisualAbstract

Another antigen associated with membranous nephropathy - this time protocadherin FAT1 with PLA2R negative HSCT-associated MN jasn.asnjournals.org/content/early/…

Concise and informative infographic on genetic oculorenal syndromes!

✳️ Welcome to #TenTweetNephJC, where we catch you up on the week's #NephJC chat in 10 tweets ✳️ The topic at hand was diuretic resistance, specifically compensatory post-diuretic sodium reabsorption (CPDSR). Let’s walk you through how it all flowed 💧

The Adaptive Renal Response for Volume Homeostasis During 2 Weeks of #Dapagliflozin Treatment in People With Type 2 Diabetes and Preserved Renal Function on a Sodium-Controlled Diet #T2D #visualabstract by Pablo Galindo doi.org/10.1016/j.ekir…

I remember breaking down to my Ph.D. advisor about how stupid I felt while troubleshooting a problem in my project when she handed me this paper. Years later it is still relevant to young students starting off in Science. It's ok to feel stupid, we all do on a regular basis.

Efficacy/safety of SGLT2i in a large cohort of kidney transplant recipients. All-cause mortality, DCGF, or Screat doubling was significantly lower in kidney transplant recipients w/ SGLT2i than in those without SGLT2i #Flozins #flozinate journals.lww.com/transplantjour…

Thanks Glomcon Fellowship for a great year! Grateful to Kate Kate Robson and mentor team @nehrologik Paolo Nikolai So Mythri Shankar 🇮🇳 Tanuj for their guidance and amazing leadership👏🙏. Thanks to faculty for sharing their wisdom. Congrats fellows🙌! GlomCon

A terrific group with a blooming friendship. Thank You, GlomCon you are an amazing ecosystem where everyone learns from eachother and realise that "teaching is two-way learning." A big shout out to all our directors, faculty and mentors for ensuring a brilliant education.

Excited to be at ANZSN ASM!! #ANZSNASM

We’ve learnt so much and made so many new friends! Astounding breadth of #young talent on display for this year’s #ANZSNasm! Stay tuned for more opportunities to be young with us in 2023…

Very excited to join Kidney360 Editorial Training Program. Thank you to Kidney360 Editorial Team for this amazing opportunity!

Heartfelt thanks to the organizers of #ISEVBiomarkers Carlos Salomon #Aase Handberg Metka Lenassi Lorraine O'Driscoll Saumya Das and all! #ExtracellularVesicles ISEV @IsevComms

Excited to be at ASN #KidneyWk!!

Come join us tomorrow at the GUSEV satellite event at 5:45-7:30pm AEST. Room 111-112 or via Zoom. #ISEV2024